ASSIST: A Surveillance Study of Illicit Substance Toxicity

  • Research type

    Research Study

  • Full title

    ASSIST: A Surveillance Study of Illicit Substance Toxicity – Clinical characterisation and toxicological analysis of Emergency Department presentations in Glasgow

  • IRAS ID

    313616

  • Contact name

    David J Lowe

  • Contact email

    david.lowe@glasgow.ac.uk

  • Sponsor organisation

    NHS Greater Glasgow & Clyde

  • Duration of Study in the UK

    1 years, 3 months, 0 days

  • Research summary

    Drug overdose is one of the leading causes of preventable death in the world. The UK accounted for 34% of all EU drug related deaths in the UK and Scotland’s rate is 3.6 times higher than that of the UK as a whole. A report on drug deaths in Scotland shows a continued rise and during the year 2020 there were 1339, nearly 5 times that of the year 2000.

    There are currently no accurate comprehensive methods of monitoring drug related Emergency Department (ED) attendances is Scotland. This study will allow identification of emerging drug trends and data will be shared contemporaneously with Public Health Scotland and inform the Scottish Government of current incidences. It will improve focus on tackling the drug-deaths crisis in Scotland by tracking local trends and improving knowledge of clinical characteristics of drugs at a national level.

    The aim of this study is to establish the introduction of a robust toxicology surveillance system in the ED. The study will explore the feasibility of reporting characteristics and causative agents of patients attending hospital as an emergency due to illicit substance use.

    Every patient that attends the ED due to the toxic effects of drugs which are not prescribed to them and would be considered controlled will be included in this study. Anonymous toxicological analysis of blood which is surplus to requirement will be performed in those who require admission to hospital.

    The study will be carried out at Queen Elizabeth University Hospital ED in Glasgow for one year.

    Participants will have no interaction with the research team. The data collected will be only that of the usual care they would get in the ED. As such the data is anonymised and consent for participation is not required.

  • REC name

    West of Scotland REC 5

  • REC reference

    22/WS/0047

  • Date of REC Opinion

    27 Apr 2022

  • REC opinion

    Favourable Opinion